Billiontoone (NASDAQ:BLLN) SVP Sells $150,959.76 in Stock

Billiontoone, Inc. (NASDAQ:BLLN) SVP Bosch John Roderick Ten sold 1,416 shares of the stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $106.61, for a total value of $150,959.76. Following the sale, the senior vice president directly owned 23,635 shares in the company, valued at $2,519,727.35. This trade represents a 5.65% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bosch John Roderick Ten also recently made the following trade(s):

• On Wednesday, September 9th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $97.54, for a total transaction of $138,116.64.
• On Tuesday, August 25th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The shares were sold at an average price of $100.00, for a total transaction of $141,700.00.
• On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $92.86, for a total value of $131,582.62.
• On Monday, June 29th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The stock was sold at an average price of $120.00, for a total value of $169,920.00.

Billiontoone Price Performance

BLLN stock opened at $123.08 on Friday. The firm has a 50 day simple moving average of $108.73 and a two-hundred day simple moving average of $98.32. The stock has a market cap of $5.81 billion and a PE ratio of 175.83. Billiontoone, Inc. has a one year low of $61.96 and a one year high of $150.44. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 EPS for the quarter, meeting the consensus estimate of $0.15. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%.The firm had revenue of $109.45 million for the quarter. On average, analysts predict that Billiontoone, Inc. will post 0.83 EPS for the current fiscal year.

Hedge Funds Weigh In On Billiontoone

Hedge funds have recently bought and sold shares of the company. Integrated Wealth Concepts LLC purchased a new position in Billiontoone in the 2nd quarter worth about $29,000. MCF Advisors LLC boosted its holdings in shares of Billiontoone by 330.8% during the 2nd quarter. MCF Advisors LLC now owns 448 shares of the company’s stock valued at $54,000 after acquiring an additional 344 shares during the last quarter. Thrive Wealth Management LLC bought a new stake in shares of Billiontoone in the second quarter worth approximately $240,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of Billiontoone in the fourth quarter worth approximately $230,000. Finally, Jasper Ridge Partners L.P. purchased a new position in shares of Billiontoone during the second quarter valued at approximately $615,000.

Analyst Ratings Changes

BLLN has been the topic of several research analyst reports. Zacks Research cut Billiontoone from a “hold” rating to a “strong sell” rating in a research note on Monday, August 31st. BTIG Research dropped their price target on Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a research note on Thursday, August 6th. Canaccord Genuity Group assumed coverage on shares of Billiontoone in a report on Wednesday, September 2nd. They issued a “buy” rating and a $120.00 price target on the stock. Wall Street Zen downgraded shares of Billiontoone from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Billiontoone in a research report on Friday, September 18th. Seven analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Billiontoone has a consensus rating of “Hold” and a consensus target price of $125.88.

Billiontoone Company Profile

BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company’s technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.

The company’s primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.